NVO Latest Headlines

Is Novo Nordisk Stock (NVO) a Good Buy After Today’s Plunge?

at www.tipranks.com (Fri, 31-Jul 6:18 PM)

Catalyst Watch: Jobs report, SpaceX's first report, AMD, and SK Hynix ratings

at seekingalpha.com (Fri, 31-Jul 3:00 PM)

Monte Rosa, BioAge plunge as Novo’s setback casts a shadow over pipeline

at seekingalpha.com (Fri, 31-Jul 2:09 PM)

J.P. Morgan Remains a Hold on Novo Nordisk (0QIU)

at www.tipranks.com (Fri, 31-Jul 10:55 AM)

Novo Nordisk’s ZEUS Trial Finds No Cardiovascular Event Reduction With Ziltivekimab

at www.tipranks.com (Fri, 31-Jul 9:18 AM)

Novo Nordisk drops as anti-inflammatory drug fails in late-stage trial

at seekingalpha.com (Fri, 31-Jul 9:01 AM)

Novo Nordisk Stock (NVO) Plunges 10% as Weight-Loss Drug Trial Disappoints

at www.tipranks.com (Fri, 31-Jul 8:22 AM)

Novo Nordisk to face shareholder lawsuit accusing fraud over CagriSema trial

at seekingalpha.com (Tue, 28-Jul 2:08 PM)

Novo Nordisk’s ZEUS Trial Reaches Completion: What It Could Mean for NVO Investors

at www.tipranks.com (Tue, 28-Jul 12:30 PM)

Wall Street Analysts Are Neutral on Top Healthcare Picks

at www.tipranks.com (Tue, 28-Jul 9:00 AM)

Novo Nordisk Boosts Treasury Stock as 2026 Share Buyback Passes DKK 7.1 Billion

at www.tipranks.com (Mon, 27-Jul 8:27 AM)

Novo Nordisk Stands at the Center of a $190 Billion Weight-Loss Boom—But New Frontiers Emerge in Tissue Restoration

Market Chameleon (Wed, 8-Jul 7:13 AM)

Novo Nordisk Expands Its GLP-1 Leadership: New Phase 3 Data Points to Long-Term Growth Beyond Diabetes

Market Chameleon (Thu, 7-May 9:46 AM)